This report presents the results of the sixth round of the Salmonella External Quality Assessment (EQA) scheme for typing of Salmonella enterica spp. enterica (further EQA-6).
This report presents the results of the fifth round of the Salmonella External Quality Assessment (EQA) scheme for typing of Salmonella enterica spp. enterica (further EQA-5).
This ECDC infographic explains how antivirals treat and protect against influenza. The recommendations to treat patients with severe influenza are based on the evidence from randomised controlled trials, observational studies, extrapolation from studies, and a generally benign safety profile of these medicines.
An ECDC expert opinion concludes that there is clear evidence supporting the use of neuraminidase inhibitors in the treatment and prevention of influenza. Moreover, the current recommendations in European countries on the use of the neuraminidase inhibitors oseltamivir and zanamivir are appropriate and should be applied by prescribing physicians.
The Director’s Annual Report provides an overview of the Centre’s accomplishments for the previous year and a summary of the Centre’s financial and administrative operations.
A consultation with European and international public health experts was convened to review data presented in newly conducted systematic reviews and meta-analyses regarding influenza antivirals, in order to develop an ECDC Expert Opinion.
This report summarises key issues related to HIV and people who inject drugs in Europe and Central Asia based on data provided by countries for reporting on the Dublin Declaration in 2018.
The Director’s Annual Report provides an overview of the Centre’s accomplishments for the previous year and a summary of the Centre’s financial and administrative operations. The Annual Report is available in PDF form.